Central Army Hospital RSPAD Gatot Soebroto Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial
2015
NCT02146664
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Central Army Hospital RSPAD Gatot Soebroto

Active Ingredients

Drugs in Phase 3 Trials (1)

dlbs1033 (1 trial)

Drugs in Phase 2 Trials (1)

av-covid-19 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Infarction (Phase 3)

Myocardial Infarction (Phase 3)

Non-ST Elevated Myocardial Infarction (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2